Outcomes with drug-coated balloons versus drug-eluting stents for patients with de novo large-vessel coronary artery disease: an updated meta-analysis
Randomized controlled trials have established the role of drug-coated balloon (DCB) for in-stent restenosis and small-vessel coronary artery disease. However, the role of DCB for large-vessel disease (LVD) remains not well established. Electronic databases were searched for studies comparing the clinical outcomes with DCB versus drug-eluting stents (DES) for de novo LVD. The primary outcome was target lesion revascularization (TLR). The secondary endpoints included cardiac mortality, all-cause mortality, myocardial infarction, and major adverse cardiac events (MACE). The angiographic outcomes were late lumen loss (LLL) and acute lumen gain. Summary estimates were pooled using a random-effects model. The pooled analysis showed lower TLR with DCB than DES (2.3% vs. 4.0%; OR = 0.58, 95% CI 0.35–0.98). DCB was associated with lower LLL (MD = − 0.18, 95% CI − 0.30 to − 0.10), whereas DES was associated with greater acute lumen gain (MD = − 0.52, 95% CI − 0.69 to − 0.34). There was no significant difference in MACE, cardiac mortality, all-cause mortality, or myocardial infarction, with pooled ORs (95% CIs) of 0.96 (0.54–1.70), 0.68 (0.37–1.26), 1.05 (0.77–1.43), and 1.05 (0.57–1.92), respectively. Among patients with LVD, DCB might be a reasonable alternative to DES. Additional randomized trials with longer follow-up are needed to confirm these findings.
Authors
- Ahmed Elazab (ORCID: https://orcid.org/0009-0004-1979-3706)
- Islam Y. Elgendy (ORCID: https://orcid.org/0000-0001-9853-7591)
- Ahmed A. Elfeky
- Mustafa M. Turkmani (ORCID: https://orcid.org/0009-0001-4261-0638)
- Amr Galal
- Ameer Awashra (ORCID: https://orcid.org/0009-0002-5122-8200)
- Mohammed A. Elbahloul (ORCID: https://orcid.org/0009-0009-3083-857X)
- Ahmed Wael Hageen (ORCID: https://orcid.org/0009-0000-0933-0426)
- Ahmed Elbataa (ORCID: https://orcid.org/0009-0009-7065-381X)
- Ahmed Mansour (ORCID: https://orcid.org/0009-0008-8938-5723)
- Ammer Alabed (ORCID: https://orcid.org/0009-0001-7290-2236)
- Alaa Abdrabou Abouelmagd (ORCID: https://orcid.org/0009-0004-5449-8833)
- Ahmed I. Elsekhary (ORCID: https://orcid.org/0009-0002-2952-7685)
- Mohamed R. Murad (ORCID: https://orcid.org/0009-0007-3518-9703)
- Sohaila Mansour Abdelsatar
- Mohammed Sabri Hassanin
- Osama Hasan Emam
Institutions
- Beni-Suef University (EG)
- Kafrelsheikh University (EG)
- University of Kentucky (US)
- Cairo University (EG)
- An-Najah National University (PS)
- Al-Azhar University (EG)
- South Valley University (EG)
- Tanta University (EG)
- Michigan State University (US)
- Damascus University (SY)
- University of Toledo (US)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1186/s40001-026-05461-y
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00